Table 6. Clinicopathological variables for 5-year disease-free and overall survival in the univariate analysis.

Variables	Disease-free survival			Overall survival
	χ2	P value		χ2	P value
Standard endocrine therapy (yes vs. no)	6.4661	0.0110		1.0993	0.2944
Luminal subtype (luminal A vs. luminal B)	2.3241	0.1274		3.6774	0.0552
Clinical stage (II vs. III)	39.7845	<0.001		16.9809	<0.001
Pre-treatment LMR (>5.2 vs. ≤5.2)	3.0533	0.0806		1.0162	0.3134
Pathological stage (0–II vs. III)	5.7243	0.0167		1.6589	0.1978
Histological stage (I–I II vs. III)	6.0889	0.0136		2.862	0.091
ypN0 (yes vs. no)	0.6955	0.4043		5.1562	0.0232
TIL (≤10% vs. >10%)	6.7047	0.010		0.6489	0.4205

LMR, lymphocyte-to-monocyte ratio; TIL, tumor-infiltrating lymphocytes; ypN0, N0 after neoadjuvant chemotherapy.